Ensoma

Boston, United States

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

$53.0M raised

Sep 2025

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ensoma raised?

Ensoma has raised $53.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.

Who are Ensoma's investors?

Ensoma's investors include Bill & Melinda Gates Foundation, Cormorant Asset Management, Catalio Capital Management, RTW Investments, Gilead Sciences.

Where is Ensoma headquartered?

Ensoma is headquartered in Boston, United States.

What does Ensoma do?

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

What stage is Ensoma at?

Ensoma is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 22, 2025.

MLA

"Ensoma — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/ensoma. Accessed July 3, 2026.

APA

VCBacked. (2025). Ensoma — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/ensoma

Wikipedia (cite web)

{{cite web |title=Ensoma — Funding & Investors |url=https://www.vcbacked.co/company/ensoma |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 22, 2025.